THC Therapeutics THCT Stock
THC Therapeutics Price Chart
THC Therapeutics THCT Financial and Trading Overview
| THC Therapeutics stock price | 0.0001 USD |
| Previous Close | 0.0028 USD |
| Open | 0.0028 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0028 - 0.0028 USD |
| 52 Week Range | 0.0028 - 0.07 USD |
| Volume | 25 USD |
| Avg. Volume | 4.28K USD |
| Market Cap | 95.61K USD |
| Beta (5Y Monthly) | 1.33169 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
THCT Valuation Measures
| Enterprise Value | 923.32K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.569 |
Trading Information
THC Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.33169 |
| 52-Week Change | -90.32% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 USD |
| 52 Week Low | 0.0028 USD |
| 50-Day Moving Average | 0.003 USD |
| 200-Day Moving Average | 0.03 USD |
THCT Share Statistics
| Avg. Volume (3 month) | 4.28K USD |
| Avg. Daily Volume (10-Days) | 1.41K USD |
| Shares Outstanding | 34.15M |
| Float | 23.61M |
| Short Ratio | N/A |
| % Held by Insiders | 30.84% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2022 |
| Most Recent Quarter (mrq) | October 31, 2022 |
| Next Fiscal Year End | July 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -557.25% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1623476 USD |
| Net Income Avi to Common (ttm) | -3166794 USD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.56K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 831.04K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.008 |
| Book Value Per Share (mrq) | -0.153 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -281719 USD |
| Levered Free Cash Flow (ttm) | 1.8M USD |
Profile of THC Therapeutics
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 11700 W Charleston Blvd. |
| ZIP | 89135 |
| Phone | 833 420 8428 |
| Website | https://thct.io |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
THC Therapeutics, Inc. operates in the wellness industry. It engages in the developing of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested cannabis, other herbs, flowers, and tea leaves. The company was formerly known as Millennium Blockchain, Inc. and changed its name to THC Therapeutics, Inc. in September 2018. THC Therapeutics, Inc. was incorporated in 2007 and is based in Las Vegas, Nevada.
Q&A For THC Therapeutics Stock
What is a current THCT stock price?
THC Therapeutics THCT stock price today per share is 0.0001 USD.
How to purchase THC Therapeutics stock?
You can buy THCT shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for THC Therapeutics?
The stock symbol or ticker of THC Therapeutics is THCT.
Which industry does the THC Therapeutics company belong to?
The THC Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does THC Therapeutics have in circulation?
The max supply of THC Therapeutics shares is 38.87M.
What is THC Therapeutics Price to Earnings Ratio (PE Ratio)?
THC Therapeutics PE Ratio is now.
What was THC Therapeutics earnings per share over the trailing 12 months (TTM)?
THC Therapeutics EPS is -0.02 USD over the trailing 12 months.
Which sector does the THC Therapeutics company belong to?
The THC Therapeutics sector is Healthcare.